Eledon Pharmaceuticals, Inc. (ELDN) vs Lyell Immunopharma, Inc. (LYEL)
- Eledon Pharmaceuticals, Inc. ELDN 2.27 +0.89%
- Lyell Immunopharma, Inc. LYEL 8.19 +2.50%
Eledon Pharmaceuticals, Inc. and Lyell Immunopharma, Inc. are both Biotechnology companies. Eledon Pharmaceuticals, Inc. and Lyell Immunopharma, Inc. are of similar size ($195.8M and $190.2M). Eledon Pharmaceuticals, Inc. has the higher net margin (0.00% vs −920,285.2%) and the higher return on invested capital (0.00% vs −539.5%). Across the 13 metrics below, Eledon Pharmaceuticals, Inc. leads on 7 and Lyell Immunopharma, Inc. on 6.
Valuation
Profitability
| Metric | ELDN | LYEL | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 100.00% | 65.16% |
| Operating margin | 0.00% | (949,981.48%) | 0.00% |
| Net margin | 0.00% | (920,285.19%) | 0.00% |
| Free cash flow margin | 0.00% | (647,681.48%) | 0.00% |
| Return on equity | (236.51%) | (93.28%) | (56.36%) |
| Return on assets | (72.74%) | (71.34%) | (48.04%) |
| Return on invested capital | 0.00% | (539.53%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack